Alfa Veterinary 10% Dextrose

Manufacturer
Laboratorios Alfa SRL | JMM Services
Effective date
2025-08-14
Label type
PRESCRIPTION ANIMAL DRUG LABEL
Version
13
Source
full-release
Hydrated at
2026-06-01 02:44:53

Label at a glance#

ProductAlfa Veterinary 10% Dextrose
Active ingredientDEXTROSE MONOHYDRATE
Label structure13 sections

Indications and uses

10% dextrose dolution has value as a source of water and calories. It is used to decrease the excessive pressure of spinal brain fluid, also a scloerisng to treat varicose veins and decrease intracranial pressure.

Dosage and administration

As directed by a veterinarian. Dosage is dependent upon the age, weight and clinical condition of the patient as well as laboratory determinations. Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration whenever solution and container permit. All injections in plastic containers are intended for intravenous administration using sterile equipment. Addi...

Storage and handling

Store below 30ºC (86ºF).

Label contents#

Full prescribing information#

DESCRIPTION

DESCRIPTION SECTION

10% dextrose solution is sterile, non-pyrogenic for fluid and calorie replacement, and is supplied in single-dose containers for intravenous administration. Discard the unused portion. Does not contain antimicrobial agents.

Chemically, dextrose (glucose) is a monosaccaride containing an aldehyde group (an aldose). In water it exists primarily as a six membered hemi-acetal ring in equilibrium with a minor amount of the free aldehyde form and a five membered hemicetal form. Dextrose used is either an anhydrous or monohydrate form.

The Plastic container, a semi-rigid bottle, is made of a low-denisty polyethylene which is a flexible and resistant material. No venting is necessary during infusion.

 Table 1. Veterinary 10% Dextrose Injection, USP

Size (mL) 
     Composition
      (g/100 mL)
      *Osmolarity
      (mOsmol/L)
      (Calculated) 

      pH 
   Caloric Content (kcal/L) 
    Dextrose 1H2O
100         11.0                  3.2-6.5       3.2-6.5         340   
250 
500 
1000 

 No venting is necessary during infusion.

CLINICAL PHARMACOLOGY

CLINICAL PHARMACOLOGY SECTION

10% Dextrose solution has value as a source of water and calories. It is capable of inducing diuresis depending on the clinical condition of the partient.

Glucose is a nutrient of the first order, provides 4.1Kcal per gram and like all carbohydrates has the property of decreasing catabolism.

INDICATIONS AND USAGE

INDICATIONS & USAGE SECTION

10% dextrose dolution has value as a source of water and calories. It is used to decrease the excessive pressure of spinal brain fluid, also a scloerisng to treat varicose veins and decrease intracranial pressure.

undefined

WARNINGS SECTION

Veterinary 10% Dextrose Injection should not be administered simultaneously with blood through the same administration set because of the possibility of pseudo agglutination or hemolysis.

The intravenous administration of 10% Dextrose Injection can cause fluid and/or solute overloading resulting in dilution of serum electrolyte concentrations, over hydration, congested states, or pulmonary edema.

The risk of dilutive states is inversely proportional to the electrolyte concentrations of the injections.

The risk of solute overload causing congested states with peripheral and pulmonary edema is directly proportional to the electrolyte concentrations of the injections.

Excessive administration of dextrose injections may result in significant hypokalemia.

The container label for these injections bears the statement: Do not administer simultaneously with blood.

Keep out of the reach of children.

ADVERSE REACTIONS

ADVERSE REACTIONS SECTION

Reactions which may occur because of the injection or the technique of administration include febrile response, infection at the site of injection, venous thrombosis or phlebitis extending from the site of injection, extravasation and hypervolemia.

If an adverse reaction does occur, discontinue the infusion, evaluate the patient, institute appropriate therapeutic countermeasures and save the remainder of the fluid for examination if deemed necessary.

PRECAUTIONS

PRECAUTIONS SECTION

Veterinary 10% Dextrose Injection, USP should be used with caution in patients with known overt or subclinical diabetes mellitus.

Clinical evaluation and periodic laboratory determinations are necessary to monitor changes in fluid balance, electrolyte concentrations and acid base balance during prolonged parenteral therapy or whenever the condition of the patient warrants such evaluation.

This is a hypotonic solution and as such should not be used for resuscitation.

Do not administer unless solution is clear and both seal and container are intact.

DOSAGE AND ADMINISTRATION

DOSAGE & ADMINISTRATION SECTION

As directed by a veterinarian. Dosage is dependent upon the age, weight and clinical condition of the patient as well as laboratory determinations.

Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration whenever solution and container permit.

All injections in plastic containers are intended for intravenous administration using sterile equipment.

Additives may be incompatible. Complete information is not available. Those additives known to be incompatible should not be used. Consult with veterinarian, if available. If, in the informed judgment of the veterinarian, it is deemed advisable to introduce additives, use aseptic technique. Mix thoroughly when additives have been introduced.

Do not store solutions containing additives. Discard unused portion.

OVERDOSAGE

OVERDOSAGE SECTION

In an event of over hydration or solute overload, re-evaluate the patient and institute appropriate corrective measures. See Warnings, Precautions, and Adverse Reactions.

STORAGE

STORAGE AND HANDLING SECTION

Store below 30ºC (86ºF).

PRECAUTION FOR USE OF THE BOTTLE:

PRECAUTIONS SECTION

This is a single dose container and does not contain preservatives. Use the solution immediately after the bottle is opened, discard the remaining one. Squeeze and inspect the bottle, discard if leaks are found or if the solution contains visible and solid particles.

Do not administer simultaneously with blood.

Do not use it unless solution is clear, and seal is intact.

Preparation and administration

1. Check for minute leaks by squeezing the container firmly. If leaks are found, discard solution as sterility may be impaired.

2. Suspend container from eyelet support.

3. Remove Plastic protector from ports area at the bottom of container.

4. Hold the bottle in vertical position and inset pyrogen free IV administration set in the outlet port. Use aseptic Technique

To add medication

WARNING: Additives may be incompatible.

To add medication before solution administration
1. Prepare medication site.
2. Using syringe with 19 to 22 gauge needle, puncture inlet port and inject.
3. Mix solution and medication thoroughly. For high density medication such as potassium chloride, squeeze ports while ports are upright and mix thoroughly.
To add medication during solution administration
1. Close clamp on the set.
2. Prepare medication site.
3. Using syringe with 18 to 21 gauge needle, puncture inlet port and inject.
4. Remove container from IV pole and/or turn to an upright position.
5. Mix solution and medication thoroughly.
6. Return container to in use position and continue administration.

CAUTION: Federal law (USA) restricts this drug to use by or on the order of a licensed veterinarian.

PACKAGE INSERT

SPL PATIENT PACKAGE INSERT SECTION

For Animal Use Only.

INSERT_10 Dextrose_page 1INSERT_10 Dextrose_page 1INSERT_10 Dextrose_page 2INSERT_10 Dextrose_page 2INSERT_10 Dextrose_page 3INSERT_10 Dextrose_page 3INSERT_10 Dextrose_page 4INSERT_10 Dextrose_page 4INSERT_10 Dextrose_page 5INSERT_10 Dextrose_page 5

 Dextrose 10% (Bottles)

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Veterinary 10% Dextrose Injection, USP

NDC: 72483-201-10 1000 mL 10% Dextrose

NDC: 72483-201-05 500 mL 10% Dextrose

NDC: 72483-201-25 250 mL 10% Dextrose

NDC: 72483-201-01 100 mL 10% Dextrose

BOTTLE_10 Dextrose_100 mlBOTTLE_10 Dextrose_100 mlBOTTLE_10 Dextrose_250 mlBOTTLE_10 Dextrose_250 mlBOTTLE_10 Dextrose_500 mlBOTTLE_10 Dextrose_500 mlBOTTLE_10 Dextrose_1000 mlBOTTLE_10 Dextrose_1000 ml

Dextrose 10% (Bags)

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Veterinary 10% Dextrose Injection, USP

NDC: 72483-201-02 5000 mL 10% Dextrose

NDC: 72483-201-03 3000 mL 10% Dextrose

NDC: 72483-201-04 1000 mL 10% Dextrose

NDC: 72483-201-06 500 mL 10% Dextrose

NDC: 72483-201-07 250 mL 10% Dextrose

NDC: 72483-201-08 100 mL 10% Dextrose

BAG_10 Dextrose_100 mlBAG_10 Dextrose_100 mlBAG_10 Dextrose_250 mlBAG_10 Dextrose_250 mlBAG_10 Dextrose_500 mlBAG_10 Dextrose_500 mlBAG_10 Dextrose_1000 mlBAG_10 Dextrose_1000 mlBAG_10 Dextrose_3000 mlBAG_10 Dextrose_3000 mlBAG_10 Dextrose_5000 mlBAG_10 Dextrose_5000 ml

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
2262603dextrose 10 % in 100 ML InjectionPSN13
1795481dextrose 10 % in 1000 ML InjectionPSN13
1795480dextrose 10 % in 250 ML InjectionPSN13
1795477dextrose 10 % in 500 ML InjectionPSN13
2262603100 ML glucose 100 MG/ML InjectionSCD13
17954811000 ML glucose 100 MG/ML InjectionSCD13
1795480250 ML glucose 100 MG/ML InjectionSCD13
1795477500 ML glucose 100 MG/ML InjectionSCD13
2262603dextrose 10 % in 100 ML InjectionSY13
1795481dextrose 10 % per 1000 ML InjectionSY13
1795480dextrose 10 % per 250 ML InjectionSY13
1795477dextrose 10 % per 500 ML InjectionSY13

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
cb89b86a-369e-4204-8910-ae797c503af3Product name120230706
d4880ace-a516-8c47-8dfd-73a4ba5887d7Product name220180830
7cda52fc-125f-421c-8fea-bc1974370c49Product name220180703
0ca1d589-929b-4b33-bc5b-1d84abdafa6aProduct name120150324
fc363c46-397b-4476-ac0f-70e43e8e4592Product name120150324

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
72483-201-01Alfa Veterinary 10% Dextrose100 mL in 1 BOTTLE, PLASTICINJECTION, SOLUTION10013
72483-201-05Alfa Veterinary 10% Dextrose500 mL in 1 BOTTLE, PLASTICINJECTION, SOLUTION50013
72483-201-10Alfa Veterinary 10% Dextrose1000 mL in 1 BOTTLE, PLASTICINJECTION, SOLUTION100013
72483-201-25Alfa Veterinary 10% Dextrose250 mL in 1 BOTTLE, PLASTICINJECTION, SOLUTION25013

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 5 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
72483-20172483-201-10, 72483-201-05, 72483-201-25, 72483-201-01

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 2 matching rows.

Name, UNII, Kind table
NameUNIIKind
DEXTROSE MONOHYDRATELX22YL083GACTIB
WATER059QF0KO0RIACT

Source Document#

Source XML · Source PDF

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 2 · 33 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
DextroseDEXTROSE MONOHYDRATEHenry Schein, Inc.8cf6943f-16e8-4521-863c-09bb0b55e2a92026-09-09Warnings, Adverse reactionsName fallback
generic name: DEXTROSE MONOHYDRATE
DextroseDEXTROSE MONOHYDRATEREMEDYREPACK INC.b8b77421-d687-45aa-82f6-d49bce644c102026-08-31Warnings, Adverse reactionsName fallback
generic name: DEXTROSE MONOHYDRATE
DextroseDEXTROSE MONOHYDRATEHospira, Inc.4ed365da-4e62-4329-c1b9-c197ab4fb6e12026-07-13Warnings, Adverse reactionsName fallback
generic name: DEXTROSE MONOHYDRATE
DextroseDEXTROSE MONOHYDRATEHospira, Inc.672264e3-9709-4bba-2a9d-12bf70c7396a2026-06-24Warnings, Adverse reactionsName fallback
generic name: DEXTROSE MONOHYDRATE
DEXTROSEDEXTROSE MONOHYDRATEBaxter Healthcare Corporation3bb406a9-f5cb-403a-b1bb-5c4facbea3d52026-06-11Warnings, Adverse reactionsName fallback
generic name: DEXTROSE MONOHYDRATE
DextroseDEXTROSE MONOHYDRATEHospira, Inc.10e98cb0-31a5-4ad1-3eaa-aa4af387a42d2026-06-02Warnings, Adverse reactionsName fallback
generic name: DEXTROSE MONOHYDRATE
DextroseDEXTROSE MONOHYDRATEHenry Schein, Inc.40fd1ac4-39bb-45fb-ba99-4fb65481f2312026-04-09Warnings, Adverse reactionsName fallback
generic name: DEXTROSE MONOHYDRATE
DextroseDEXTROSE MONOHYDRATEBecton Dickinson and Company8e7046f8-841e-465a-af69-af9fb3d6799d2026-03-17Warnings, Adverse reactionsName fallback
generic name: DEXTROSE MONOHYDRATE
DextroseDEXTROSE MONOHYDRATEFresenius Kabi USA, LLC3b8f2692-4371-4f1a-95af-b41842131fdd2026-03-13Warnings, Adverse reactionsName fallback
generic name: DEXTROSE MONOHYDRATE
DextroseDEXTROSE MONOHYDRATEBECTON DICKINSON AND COMPANY32132016-1870-481b-9816-e11beb03ca0b2026-01-08Warnings, Adverse reactionsName fallback
generic name: DEXTROSE MONOHYDRATE
DextroseDEXTROSE MONOHYDRATEFresenius Kabi USA, LLCbd250a46-d229-4e80-b5a1-b34169ccecc42025-12-17Warnings, Adverse reactionsName fallback
generic name: DEXTROSE MONOHYDRATE
DextroseDEXTROSE MONOHYDRATEICU Medical, Inc.8b25b7e0-703e-4b43-a4eb-52863511602d2025-11-02Warnings, Adverse reactionsName fallback
generic name: DEXTROSE MONOHYDRATE
DextroseDEXTROSE MONOHYDRATEICU Medical, Inc.cb578dba-094c-4787-951d-763d12fd06e12025-11-01Warnings, Adverse reactionsName fallback
generic name: DEXTROSE MONOHYDRATE
DextroseDEXTROSE MONOHYDRATEICU Medical Inc.cdf35d11-fbc8-4f8e-85a8-33220312c0b42025-10-17Warnings, Adverse reactionsName fallback
generic name: DEXTROSE MONOHYDRATE
DextroseDEXTROSE MONOHYDRATEProPharma Distribution3eff8bcd-6a33-428f-e063-6394a90afa682025-09-17Warnings, Adverse reactionsName fallback
generic name: DEXTROSE MONOHYDRATE
DextroseDEXTROSE MONOHYDRATEBaxter Healthcare Companybfc4224a-2fc9-4137-b4c6-9d2d6d9484132025-07-30Warnings, Adverse reactionsName fallback
generic name: DEXTROSE MONOHYDRATE
DextroseDEXTROSE MONOHYDRATEProPharma Distribution3842a9c0-8b15-1c94-e063-6394a90ae1202025-07-18Warnings, Adverse reactionsName fallback
generic name: DEXTROSE MONOHYDRATE
DEXTROSEDEXTROSE MONOHYDRATEBaxter Healthcare Corporation36e9478c-5df0-4b47-b97d-de3626d7cb292025-06-30Warnings, Adverse reactionsName fallback
generic name: DEXTROSE MONOHYDRATE
DextroseDEXTROSE MONOHYDRATEFRESENIUS KABI USA, LLC576a22d8-5f2f-497e-80ad-1842ca74bb532024-08-22Warnings, Adverse reactionsName fallback
generic name: DEXTROSE MONOHYDRATE
DextroseDEXTROSE MONOHYDRATEBecton Dickinson and Companyc1f72bce-4bef-49db-a8da-f26a703d67482024-08-15Warnings, Adverse reactionsName fallback
generic name: DEXTROSE MONOHYDRATE

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.